Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
The Life Sciences Report
Menu
Articles
Biotechnology / Pharmaceuticals
Cannabis
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Nutraceuticals
Psychedelics
Disclosures
Featured news in
The Life Sciences Report
Regeneus Ltd.
(RGS:ASX)
Will Receive Key Patent for Progenza from Japanese Patent Office (5/23/2017)
view
ProMIS Neurosciences Inc.
(PMN:TSX; PMN:NCM)
ProMIS Neurosciences Designates PMN350 its Second Lead Product for Development in Alzheimer’s Disease (5/24/2017)
view
Viveve Medical Inc.
(VIVE:NASDAQ)
Viveve Secures $30 million Debt Financing with CRG (5/23/2017)
view
Viveve Medical Inc.
(VIVE:NASDAQ)
Viveve to Participate in the Craig-Hallum Institutional Investor Conference (5/24/2017)
view
Inovio Pharmaceuticals Inc.
(INO:NASDAQ)
Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates in a Clinical Study (5/24/2017)
view
Celgene Corp.
(CELG:NASDAQ)
Celgene (CELG) Multiple Sclerosis Drug Meets Primary Endpoint (5/23/2017)
view
Celgene Corp.
(CELG:NASDAQ)
Biotech Stock Roundup: FDA Nod for Regeneron RA Drug, Amgen Hit by Study Data (5/24/2017)
view
Celgene Corp.
(CELG:NASDAQ)
Blog Coverage: Celgene Reported Positive Late Stage Results from Trial of Ozanimod in Patients with Relapsing Multiple Sclerosis (5/24/2017)
view
Resverlogix Corp.
(RVX:TSX)
Recent Publication and Patent Application Referencing Apabetalone Support its Continued Development and Success (5/23/2017)
view
RXi Pharmaceuticals Corp.
(PHIO:NASDAQ)
NetworkNewsBreaks - Top 10 Mid-day Percentage Gainers on May 22, 2017 (5/22/2017)
view
RXi Pharmaceuticals Corp.
(PHIO:NASDAQ)
RXi Pharmaceuticals to Present at the 3rd Annual Immuno-Oncology BD&L and Investment Forum (5/23/2017)
view
RXi Pharmaceuticals Corp.
(PHIO:NASDAQ)
PCI Biotech and RXi Pharmaceuticals Extend Research Collaboration to the Field of Immuno-oncology (5/22/2017)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
BrainStorm to Present at Cell & Gene Exchange Conference in Washington DC (5/22/2017)
view